ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2928

Associations of Socioeconomic Status with Rheumatoid Arthritis (RA) Progression in African Americans with Early Disease

Rebecca Cleveland1, Emma Astrike-Davis 1, Beth Jonas 1 and Leigh Callahan 1, 1Thurston Arthritis Research Center, Chapel Hill, NC

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: socioeconomic status and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 13, 2019

Title: 6W026: Epidemiology & Public Health (2924–2929)

Session Type: ACR/ARP Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose: In prior cross-sectional analyses of African Americans (AA) with RA, we observed that low education, income and home ownership were associated with clinical damage and patient reported outcomes (PROs) among those with mean disease duration of 7.8 years. However, when restricted to those with disease duration of < 2 years, associations with PROs remained, but were no longer observed with damage, most likely due to the low damage scores in individuals with early disease. Therefore, we hypothesize that socioeconomic status (SES) measures may be related to clinical progression and PRO worsening in AA with early RA.

Methods: We conducted analyses using data from 194 individuals with RA who completed a follow-up at 5 years of disease duration. Patients who had been diagnosed in the previous 2 years were enrolled from 5 medical centers in the southeastern US. SES measures were educational attainment (< high school diploma [< HS EDUC], or ≥HS); occupation (professional or not [Non-Pro OCC]); home ownership (yes or non-HOME); annual household income (≤$30,000 [≤$30K INC] or >$30K); and percent block group poverty (BGP ≥20% or < 20%). Outcomes were based on radiographs (erosion and JSN score) and PROs (Health Assessment Questionnaire [HAQ], self-rated pain and fatigue from visual analog scales [VAS] and the Rheumatology Attitudes Index [RAI]). Progression was defined as those who were in the highest quintile of disease progression (top 20% of increases in severity of outcome scores): erosions ≥1, JSN ≥7, HAQ ≥0.37, Pain and Fatigue VAS ≥3, RAI ≥0.4. We multiply imputed missing values of covariates. Multi-level logistic regression models with study site considered as a random effect were used to estimate odds ratios (OR) and 95% confidence intervals (CI) for the association between SES measures at baseline and progression. All models were adjusted for age, sex, BMI, number of comorbidities, smoking, disease duration at study entry, methotrexate/leflunomide use, and were simultaneously adjusted for other SES measures.

Results: Baseline demographics are shown in Table 1. At 5 years disease duration, mean outcome scores tended to increase for both erosion scores and JSN scores, but decreased for PROs (Table 2). We did not observe any association between SES measures and either erosion or JSN score progression (Table 3). However, < HS EDUC and Non-Pro OCC were both associated with worsening pain VAS, while non-HOME was inversely associated with worsening pain VAS, and non-Pro OCC was inversely associated with worsening RAI.

Conclusion: As with the previous cross-sectional analyses examining associations between SES measures and outcomes in AAs with < 2 years of disease who are being treated with RA therapies, we did not observe associations between SES and radiographic progression in adjusted analyses. However, some SES measures were associated with increased Pain VAS, after simultaneously adjusting for all SES measures and covariates. These results are possibly due to the relatively short disease duration (5 years) and length of follow-up (4 years) of the population and warrants further research with longer periods of follow-up.


SES & RA Table 1

Baseline Characteristics


SES & RA Table 2a

Outcome measures over time


SES & RA Table 3a

SES Predictors of RA Radiographic and Patient Reported Outcomes Progression


Disclosure: R. Cleveland, None; E. Astrike-Davis, None; B. Jonas, None; L. Callahan, None.

To cite this abstract in AMA style:

Cleveland R, Astrike-Davis E, Jonas B, Callahan L. Associations of Socioeconomic Status with Rheumatoid Arthritis (RA) Progression in African Americans with Early Disease [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/associations-of-socioeconomic-status-with-rheumatoid-arthritis-ra-progression-in-african-americans-with-early-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/associations-of-socioeconomic-status-with-rheumatoid-arthritis-ra-progression-in-african-americans-with-early-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology